Engagement of the cellular receptor for glycoprotein B of human cytomegalovirus activates the interferon-responsive pathway

Molecular and Cellular Biology

Volumn 19, Issue 5, 1999, Pages 3607-3613

  Boyle, Kathleen A ^a   Pietropaolo, Robin L ^a   Compton, Teresa ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA INTERFERON RECEPTOR; BETA INTERFERON; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; GLYCOPROTEIN B; INTERFERON; MITOGEN ACTIVATED PROTEIN KINASE; PROTEOHEPARAN SULFATE; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

ARTICLE; ENZYME ACTIVATION; GENE ACTIVATION; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

CYTOMEGALOVIRUS; DNA VIRUSES; HUMAN HERPESVIRUS 5;

EID: 0032931994     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.5.3607     Document Type: Article

References (80)

1. Akiyama, T., J. Ishida, S. Nakagawa, H. Ogawara, S. Watanabe, N. Itoh, M. Shibuya, and Y. Fukami. 1987. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262:5592-5595.
2. Albrecht, T., I. Boldogh, M. Fons, S. AbuBakar, and C. Z. Deng. 1990. Cell activation signals and the pathogenesis of human cytomegalovirus. Intervirology 31:68-75.
3. Albrecht, T., I. Boldogh, M. Fons, C. H. Lee, S. AbuBakar, J. M. Russell, and W. W. Au. 1989. Cell-activation responses to cytomegalovirus infection. Relationship to the phasing of CMV replication and to the induction of cellular damage. Subcell. Biochem. 15:157-202.
4. Alford, C. A., and W. J. Britt. 1993. Cytomegalovirus, p. 227-255. In B. Roizman, R. J. Whitley, and C. Lopex (ed.), Human herpesviruses. Raven Press, New York, N.Y.
5. Au, W. C., P. A. Moore, W. Lowther, Y. T. Juang, and P. M. Pitha. 1995. Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes. Proc. Natl. Acad. Sci. USA 92:11657-11661.
6. Baglioni, C., M. A. Minks, and P. A. Maroney. 1978. Interferon action may be mediated by activation of a nuclease by pppA2′p5′A2′p5′A. Nature 273:684-687.
7. Baldari, C. T., E. Milia, M. M. Di Somma, F. Baldoni, S. Valitutti, and J. L. Telford. 1995. Distinct signaling properties identify functionally different CD4 epitopes. Eur. J. Immunol. 25:1843-1850.
8. Boldogh, I., S. AbuBakar, and T. Albrecht. 1990. Activation of proto-oncogenes: an immediate early event in human cytomegalovirus infection. Science 247:561-564.
9. Boldogh, I., M. P. Fons, and T. Albrecht. 1993. Increased levels of sequence-specific DNA-binding proteins in human cytomegalovirus infected cells. Biochem. Biophys. Res. Commun. 197:1505-1510.
10. Boulton, T. G., J. S. Gregory, and M. H. Cobb. 1991. Purification and properties of extracellular signal-regulated kinase 1, and insulin-stimulated microtubule-associated protein 2 kinase. Biochemistry 30:278-286.
11. Boyle, K. A., and T. Compton. 1998. Receptor binding properties of a soluble form of human cytomegalovirus glycoprotein B. J. Virol. 72:1826-1833.
12. 11a. Boyle, K. A., and T. Compton. Unpublished results.
13. Briant, L., N. Signoret, M. Gaubin, V. Robert-Hebmann, X. Zhang, R. Murall, M. I. Greene, D. Piatier-Tonneau, and C. Devaux. 1997. Transduction of activation signal that follows HIV-1 binding to CD4 and CD4 dimerization involves the immunoglobulin CDR3-like region in domain 1 of CD4. J. Biol. Chem. 272:19441-19450.
14. Britt, W. J., and C. A. Alford. 1996. Cytomegalovirus:, p. 2493-2523. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Virology. Lippincott-Raven Publishers, Philadelphia, Pa.
15. Britt, W. J., and M. Mach. 1996. Human cytomegalovirus glycoproteins. Intervirology 39:401-412.
16. Carlson, C., W. J. Britt, and T. Compton. 1997. Expression, purification and characterization of a soluble form of human cytomegalovirus glycoprotein B. Virology 239:168-205.
17. Cirone, M., A. Angeloni, G. Barile, C. Zompetta, M. Venanzoni, M. R. Torrisi, L. Frati, and A. Faggioni. 1990. Epstein Barr virus internalization and infectivity are blocked by selective protein kinase C inhibitors. Int. J. Cancer 45:490-493.
18. Clemens, M. J., and B. R. G. Williams. 1976. Inhibition of cell-free protein synthesis by pppA2′p5′A2′p5′A: a novel oligonucleotide synthesized by interferon treated cell extracts. Cell 13:565-572.
19. Cobb, M. H., and E. J. Goldsmith. 1995. How MAP kinases are regulated. J. Biol. Chem. 270:14843-14846.
20. 18a. Colamonici, O. R., and T. Compton. Unpublished results.
21. Colamonici, O. R., H. Uyttendaele, P. Domanski, H. Yan, and J. J. Krolewski. 1994. p135tyk2, an interferon-alpha-activated tyrosine kinase, is physically associated with an interferon-alpha receptor. J. Biol. Chem. 269:3518-3522.
22. Compton, T. 1993. An immortalized human fibroblast cell line is permissive for human cytomegalovirus infection. J. Virol. 67:3644-3648.
23. Compton, T. 1995. Towards a definition of the HCMV entry pathway. Scand. J. Infect. Dis. 99:30-32.
24. Compton, T., R. R. Nepomuceno, and D. M. Nowlin. 1992. Human cytomegalovirus penetrates host cells by pH-independent fusion at the cell surface. Virology 191:387-395.
25. Compton, T., D. M. Nowlin, and N. R. Cooper. 1993. Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate. Virology 193:834-841.
26. Darnell, J. E., Jr., I. M. Kerr, and G. R. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415-1421.
27. David, M., E. Petricoin III, C. Benjamin, R. Pine, M. J. Weber, and A. C. Larner. 1995. Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins. Science 269:1721-1723.
28. + T-cell clones specifically activated by IE1 peptides in vitro. J. Virol. 70:2162-2169.
29. Domanski, P., and O. R. Colamonici. 1996. The type-I interferon receptor. The long and short of it. Cytokine Growth Factor Rev. 7:143-151.
30. Farrar, G. H., and P. J. Greenaway. 1986. Characterization of glycoprotein complexes present in human cytomegalovirus envelopes. J. Gen. Virol. 67: 1469-1473.
31. Farrar, M. A., and R. D. Schreiber. 1993. The molecular cell biology of interferon-gamma and its receptor. Annu. Rev. Immunol. 11:571-611.
32. Fu, X.-Y., C. Schindler, T. Improta, R. Aebersold, and J. E. Darnell. 1992. The proteins of ISGF3, the interferon a-induced transcriptional activator, define a gene family involved in signal transduction. Proc. Natl. Acad. Sci. USA 89:7840-7843.
33. Gazit, A., P. Yaish, C. Gilon, and A. Levitzki. 1989. Tyrphostins. I. Synthesis and biological activity of protein tyrosine kinase inhibitors. J. Med. Chem. 32:2344-2352.
34. Gilmore, K. C., and N. C. Reich. 1995. Signal transduction and activation of gene transcription by interferons. Gene Exp. 5:1-18.
35. Gopalakrishna, R., Z. H. Chen, and U. Gundimeda. 1992. Irreversible oxidative inactivation of protein kinase C by photosensitive inhibitor calphostin C. FEBS Lett. 314:149-154.
36. Greenberg, M. E., A. L. Hermanowski, and E. B. Ziff. 1986. Effect of protein synthesis inhibitors on growth factor activation of c-fos, c-myc, and actin gene transcription. Mol. Cell. Biol. 6:1050-1057.
37. Gretch, D. R., R. C. Gehrz, and M. F. Stinski. 1988. Characterization of a human cytomegalovirus glycoprotein complex (gcI). J. Gen. Virol. 69:1205-1215.
38. Harel, N. Y., and J. C. Alwine. 1998. Phosphorylation of the human cytomegalovirus 86-kilodalton immediate-early protein IE2. J. Virol. 72:5481-5492.
39. Ibanez, C. E., R. Schrier, P. Ghazal, C. Wiley, and J. A. Nelson. 1991. Human cytomegalovirus productively infects primary differentiated macrophages. J. Virol. 65:6581-6588.
40. Kari, B., and R. Gehrz. 1992. A human cytomegalovirus glycoprotein complex designated gC-II is a major heparin-binding component of the envelope. J. Virol. 66:1761-1764.
41. Kobayashi, E., H. Nakano, M. Morimoto, and T. Tamaoki. 1989. Calphostin C (UCN-1028C) a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 159:548-553.
42. Kowalik, T. F., B. Wing, J. S. Haskill, J. C. Azizkhan, A. S. Baldwin, and E. Huang. 1993. Multiple mechanisms are implicated in the regulation of NF-κB activity during human cytomegalovirus infection. Proc. Natl. Acad. Sci. USA 90:1107-1111.
43. Lathey, J. L., and S. A. Spector. 1991. Unrestricted replication of human cytomegalovirus in hydrocortisone-treated macrophages. J. Virol. 65:6371-6375.
44. Levy, D. E., D. S. Kessler, R. Pine, and J. E. Darnell, Jr. 1989. Cytoplasmic activation of ISGF3, the positive regulator of interferon-alpha-stimulated transcription, reconstituted in vitro. Genes Dev. 3:1362-1371.
45. Levy, D. E., D. J. Lew, D. S. Kessler, and J. E. Darnell. 1990. Synergistic interaction between interferon-α and interferon-γ through induced synthesis of one subunit of the transcription factor ISGF3. EMBO J. 9:1105-1111.
46. Liu, B., and M. F. Stinski. 1992. Human cytomegalovirus contains a tegu-ment protein that enhances transcription from promoters with upstream ATF and AP-1 cis-acting elements. J. Virol. 66:4434-4444.
47. Luxembourg, A. T., and N. R. Cooper. 1994. Modulation of signaling via the B cell antigen receptor by CD21, the receptor for C3dg and EBV. J. Immunol. 153:4448-4457.
48. Meier, J. L., and M. F. Stinski. 1996. Regulation of human cytomegalovirus immediate-early gene expression. Intervirology 39:331-42.
49. Miller, D. M., B. M. Rahill, J. M. Boss, M. D. Lairmore, J. E. Durbin, J. W. Waldman, and D. D. Sedmak. 1998. Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J. Exp. Med. 187:675-683.
50. Minton, E. J., C. Tysoe, J. H. Sinclair, and J. G. Sissons. 1994. Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow. J. Virol. 68:4017-4021.
51. Navarro, D., P. Paz, S. Tugizov, K. Topp, J. La Vail, and L. Pereira. 1993. Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells. Virology 197:143-158.
52. Navarro, L., K. Mowen, S. Rodems, B. Weaver, N. Reich, D. Spector, and M. David. 1998. Cytomegalovirus activates interferon immediate-early response gene expression and an interferon regulatory factor 3-containing interferon-stimulated response element-binding complex. Mol. Cell. Biol. 18:3796-3802.
53. Nemerow, G. R., and N. R. Cooper. 1984. Early events in the infection of human B lymphocytes by Epstein-Barr virus: the internalization process. Virology 132:186-198.
54. Neyts, J., R. Shoeck, D. Schols, J. Balzarini, J. D. Esko, S. A. Van, and C. E. De. 1992. Sulfated polymers inhibit the interaction of human cytomegalovirus with cell surface heparan sulfate. Virology 189:48-58.
55. Pereira, L. 1994. Function of glycoprotein B homologues of the family Herpesviridae. Infect. Agents Dis. 3:9-28.
56. Rapraeger, A. C., A. Krufka, and B. B. Olwin. 1991. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 252:1705-1708.
57. Ratner, L., R. C. Wiegand, P. J. Farrell, G. C. Sen, and P. Lengyel. 1978. Interferon, double stranded RNA and RNA degradation. Fractionation of the endonuclease INT system into two macromolecular components: role of a small molecule in nuclease activation. Biochem. Biophys. Res. Commun. 81:947-954.
58. Roberts, M. L., A. T. Luxembourg, and N. R. Cooper. 1996. Epstein-Barr virus binding to CD21, the virus receptor, activates resting B cells via an intracellular pathway thai is linked to B cell infection. J. Gen. Virol. 77(Pt. 12):3077-3085.
59. Rossi, D., L. Del Giacco, L. Doneda, U. Nicolini, B. Acaia, D. Brioschi, and L. Larizza. 1996. Expression pattern of c-sis, c-fos, and c-jun in human placenta and embryofetal organs. Gynecol. Obstetr. Investig. 42:1-7.
60. Sambucetti, L. C., J. M. Cherrington, G. W. G. Wilkenson, and E. S. Mocarski. 1989. NF-κB activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation. EMBO J. 8:4251-4258.
61. Segar, R., and E. G. Krebs. 1995. The MAPK signaling cascade. FASEB J. 9:726-735.
62. Sinclair, J. H., J. Baillie, L. A. Bryant, J. A. Taylor-Wiedeman, and J. G. Sissons. 1992. Repression of human cytomegalovirus major immediate early gene expression in a monocytic cell line. J. Gen. Virol. 73(Pt. 2):433-435.
63. Soderberg-Naucler, C., K. N. Fish, and J. A. Nelson. 1997. Interferon-gamma and tumor necrosis factor-alpha specifically induce formation of cytomegalovirus-permissive monocyte-derived macrophages that are refractory to the antiviral activity of these cytokines. J. Clin. Investig. 100:3154-3163.
64. Soderberg-Naucler, C., K. N. Fish, and J. A. Nelson. 1997. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 91:119-126.
65. Spear, P. G. 1993. Entry of alphaherpesviruses into cells. Semin. Virol. 4:167-180.
66. Stein, B. S., S. D. Gowda, J. D. Lifson, R. C. Penhallow, K. G. Bensch, and E. G. Engleman. 1987. pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane. Cell 49:659-668.
67. Stenberg, R. M., and J. A. Kerry. 1995. Cytomegalovirus genes: their structure and function. Scand. J. Infect. Dis. Suppl. 99:3-6.
68. Sugano, N., W. Chen, M. L. Roberts, and N. R. Cooper. 1997. Epstein-Barr virus binding to CD21 activates the initial viral promoter via NF-kappaB induction. J. Exp. Med. 186:731-737.
69. Takahashi, I., E. Kobayashi, H. Nakano, C. Murakata, H. Saitoh, K. Suzuki, and T. Tamaoki. 1990. Potent selective inhibition of 7-O-methyl UCN-01 against protein kinase C. J. Pharmacol. Exp. Ther. 255:1218-1221.
70. Taylor-Wiedeman, J., J. G. Sissons, L. K. Borysiewicz, and J. H. Sinclair. 1991. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J. Gen. Virol. 72(Pt. 9):2059-2064.
71. Taylor-Wiedeman, J., P. Sissons, and J. Sinclair. 1994. Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers. J. Virol. 68:1597-1604.
72. Torigoe, S., D. E. Campbell, and S. E. Starr. 1997. Cytokines released by human peripheral blood mononuclear cells inhibit the production of early and late cytomegalovirus proteins. Microbiol. Immunol. 41:403-413.
73. Tugizov, S., D. Navarro, P. Paz, Y. Wang, I. Qadri, and L. Pereira. 1994. Function of human cytomegalovirus glycoprotein B: syncytium formation in cells constitutively expressing gB is blocked by virus-neutralizing antibodies. Virology 201:263-276.
74. Valy-Nagy, T., Z. Bandi, I. Boldogh, and T. Albrecht. 1988. Hydrolysis of inositol lipids: an early signal of human cytomegalovirus infection. Arch. Virol. 101:199-207.
75. Weissman, D., R. L. Rabin, J. Arthos, A. Rubbert, M. Dybul, R. Swofford, S. Venkatesan, J. M. Farber, and A. S. Fauci. 1997. Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor. Nature 389:981-985.
76. Yamamoto, N., K. Shimokata, K. Maeno, and Y. Nishiyama. 1987. Effect of recombinant human interferon-gamma against human cytomegalovirus. Arch. Virol. 94:323-329.
77. Yurochko, A. D., E. Hwang, L. Rasmussen, S. Keay, L. Pereira, and E. Huang. 1997. The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-κB during infection. J. Virol. 71:5051-5059.
78. Yurochko, A. D., T. F. Kowalik, S. Huong, and E. Huang. 1995. Human cytomegalovirus upregulates NF-κB activity by transactivating the NF-κB p105/p50 and p65 promoters. J. Virol. 69:5391-5400.
79. Yurochko, A. D., M. W. Mayo, E. E. Poma, A. S. Baldwin, and E. Huang. 1997. Induction of the transcription factor Sp1 during human cytomegalovirus infection mediates upregulation of the p65 and p105/p50 NF-κB promoters. J. Virol. 71:4638-4648.
80. Zhu, H., J. Cong, and T. Shenk. 1997. Use of differential display analysis to assess the effect of human cytomegalovirus infection on the accumulation of cellular RNAs: Induction of interferon-responsive RNAs. Proc. Natl. Acad. Sci. USA 94:13985-13990.